BRIDGEWAY CAPITAL MANAGEMENT, LLC - ENTASIS THERAPEUTICS HLDGS I ownership

ENTASIS THERAPEUTICS HLDGS I's ticker is ETTX and the CUSIP is 293614103. A total of 23 filers reported holding ENTASIS THERAPEUTICS HLDGS I in Q2 2020. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
BRIDGEWAY CAPITAL MANAGEMENT, LLC ownership history of ENTASIS THERAPEUTICS HLDGS I
ValueSharesWeighting
Q2 2022$292,000
+17.7%
132,6000.0%0.01%
+40.0%
Q1 2022$248,000
+2.9%
132,600
+20.5%
0.01%
+25.0%
Q4 2021$241,000
-34.3%
110,0000.0%0.00%
-42.9%
Q3 2021$367,000
+24.8%
110,0000.0%0.01%
+40.0%
Q2 2021$294,000
+14.4%
110,000
-8.3%
0.01%0.0%
Q1 2021$257,000
-13.2%
120,0000.0%0.01%
-16.7%
Q4 2020$296,000
+107.0%
120,000
+71.4%
0.01%
+100.0%
Q3 2020$143,000
-30.9%
70,0000.0%0.00%
-25.0%
Q2 2020$207,000
+132.6%
70,000
+100.0%
0.00%
+100.0%
Q1 2020$89,00035,0000.00%
Other shareholders
ENTASIS THERAPEUTICS HLDGS I shareholders Q2 2020
NameSharesValueWeighting ↓
Eventide Asset Management 590,602$1,577,0000.02%
TPG Group Holdings (SBS) Advisors, Inc. 1,020,748$2,725,0000.02%
OCCUDO QUANTITATIVE STRATEGIES LP 23,058$62,0000.01%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 110,000$294,0000.01%
Alberta Investment Management Corp 130,000$347,0000.00%
Jaffetilchin Investment Partners, LLC 11,000$29,0000.00%
TWO SIGMA INVESTMENTS, LP 164,229$438,0000.00%
TWO SIGMA ADVISERS, LP 162,942$435,0000.00%
Janney Montgomery Scott LLC 69,487$186,0000.00%
Renaissance Technologies 391,629$1,046,0000.00%
View complete list of ENTASIS THERAPEUTICS HLDGS I shareholders